Vanda Pharmaceuticals (VNDA) Inventory Average (2012 - 2026)
Vanda Pharmaceuticals (VNDA) posted Inventory Average of $6.4 million for Q1 2026, down 39.6% sequentially from $10.5 million in Q4 2025, and up 11.22% YoY from $5.7 million in Q1 2025.
Vanda Pharmaceuticals (VNDA) Inventory Average (2012 - 2026) Analysis & Trends
Vanda Pharmaceuticals has reported Inventory Average for 15 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Inventory Average rose 11.22% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 11.22% YoY) and the FY2025 annual result came in at $10.3 million, up 88.9% from the prior year.
- Inventory Average fell to $6.4 million in Q1 2026 per VNDA's latest filing, from $10.5 million in the prior quarter.
- Over five years, Inventory Average peaked at $11.3 million in Q4 2022 and troughed at $1.4 million in Q2 2022.
- A 5-year average of $6.5 million and a median of $6.1 million in 2025 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2024: Inventory Average surged 649.07% in 2023, then tumbled 87.1% in 2024.
- Over 5 years, Inventory Average stood at $11.3 million in 2022, then slumped by 48.55% to $5.8 million in 2023, then surged by 64.23% to $9.5 million in 2024, then rose by 10.54% to $10.5 million in 2025, then slumped by 39.6% to $6.4 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $6.4 million, $10.5 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn | 10.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.32 Mn |
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 10.53 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 5.72 Mn |
| Dec 31, 2024 | 9.53 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 10.21 Mn |
| Jun 30, 2023 | 10.43 Mn |
| Mar 31, 2023 | 11.09 Mn |
| Dec 31, 2022 | 11.27 Mn |
| Sep 30, 2022 | 6.28 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 4.77 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 4.62 Mn |